Literature DB >> 20723040

Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C.

R K Gieseler1, G Marquitan, M Schlattjan, J-P Sowa, L P Bechmann, J Timm, M Roggendorf, G Gerken, S L Friedman, A Canbay.   

Abstract

Chronic hepatitis C infection leads to increased hepatocyte apoptosis. Because engulfment of apoptotic bodies (ABs) by hepatic stellate cells (HSC) is profibrogenic, we compared the effects of ABs derived from hepatitis C virus (HCV)-negative vs HCV-infected (Con1+) Huh7 hepatoblastoma cells on fibrogenic and activation-related mRNA expression by a human HSC line (LX2). Uptake of Huh7(Con1+) ABs by LX2 cells dose dependently upregulated profibrotic genes (COL1A1, TGFB1; TIMP1; TIMP2). When normalized to the apoptotic cytokeratin-18 M30 neoepitope, HCV(+) ABs exhibited a more pronounced effect than HCV(-) ABs. In contrast, neither noningested ABs nor nucleic acids obtained from Huh7, Huh7(Con1+) or HepG2 cells triggered those AB-dependent effects. Both the engulfment of Huh7(Con1+) ABs and their effects were partially blocked by masking of phosphatidylserine with annexin V and completely inhibited by the class-A scavenger receptor ligand, polyinosinic acid. Our findings demonstrate that AB uptake stimulates HSCs and indicate that HCV infection leads to amplified fibrogenic mRNA expression and enhanced HSC activation.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723040      PMCID: PMC2995835          DOI: 10.1111/j.1365-2893.2010.01362.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  23 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 2.  The phosphatidylserine receptor: a crucial molecular switch?

Authors:  P M Henson; D L Bratton; V A Fadok
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

Review 3.  Liver fibrosis -- from bench to bedside.

Authors:  Scott L Friedman
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 4.  Apoptosis: the nexus of liver injury and fibrosis.

Authors:  Ali Canbay; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

Review 5.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

6.  Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

Authors:  L Xu; A Y Hui; E Albanis; M J Arthur; S M O'Byrne; W S Blaner; P Mukherjee; S L Friedman; F J Eng
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.

Authors:  Heike Bantel; Andreas Lügering; Jan Heidemann; Xandra Volkmann; Christopher Poremba; Christian P Strassburg; Michael Peter Manns; Klaus Schulze-Osthoff
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

8.  Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism.

Authors:  Joy X Jiang; Kenichiro Mikami; Vijay H Shah; Natalie J Torok
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.

Authors:  Ali Canbay; Ariel E Feldstein; Hajime Higuchi; Nate Werneburg; Annette Grambihler; Steve F Bronk; Gregory J Gores
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

10.  Apoptotic body engulfment by a human stellate cell line is profibrogenic.

Authors:  Ali Canbay; Pavel Taimr; Natalie Torok; Hajime Higuchi; Scott Friedman; Gregory J Gores
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

View more
  14 in total

1.  Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.

Authors:  Murali Ganesan; Sathish Kumar Natarajan; Jinjin Zhang; Justin L Mott; Larisa I Poluektova; Benita L McVicker; Kusum K Kharbanda; Dean J Tuma; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-04-07       Impact factor: 4.052

2.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 3.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

Review 4.  Hepatic stellate cells, liver innate immunity, and hepatitis C virus.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Min Sang; Wenzhe Ho
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 5.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

6.  Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.

Authors:  Murali Ganesan; Jinjin Zhang; Tatiana Bronich; Larisa I Poluektova; Terrence M Donohue; Dean J Tuma; Kusum K Kharbanda; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

7.  Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.

Authors:  Julia Kälsch; Lars P Bechmann; Hagen Kälsch; Martin Schlattjan; Jochen Erhard; Guido Gerken; Ali Canbay
Journal:  J Nutr Metab       Date:  2011-06-23

8.  Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice.

Authors:  Kerstin Herzer; Anna Carbow; Svenja Sydor; Jan-Peter Sowa; Stefan Biesterfeld; Thomas-Georg Hofmann; Peter-Robert Galle; Guido Gerken; Ali Canbay
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

Review 9.  HCV and oxidative stress in the liver.

Authors:  Alexander V Ivanov; Birke Bartosch; Olga A Smirnova; Maria G Isaguliants; Sergey N Kochetkov
Journal:  Viruses       Date:  2013-01-28       Impact factor: 5.048

10.  Novel algorithm for non-invasive assessment of fibrosis in NAFLD.

Authors:  Jan-Peter Sowa; Dominik Heider; Lars Peter Bechmann; Guido Gerken; Daniel Hoffmann; Ali Canbay
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.